Showing results (131-140 of 344) with videos related to

Sort By:
Pageof 35
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2018
Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical ImplicationHansang Lee, Ho Yun Lee, Jong-Mu Sun, et al.
Japanese Journal of Clinical Oncology|October 28, 2008
Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancerJong-Mu Sun, Keun-Wook Lee, Jee Hyun Kim, et al.
Translational Lung Cancer Research|December 3, 2021
Real-time autOmatically updated data warehOuse in healThcare (ROOT): an innovative and automated data collection systemHyun Ae Jung, Oksoon Jeong, Dong Kyung Chang, et al.
Cancer|March 11, 2020
Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancerJiyun Lee, Hong Sook Kim, Boram Lee, et al.
Cancer Research and Treatment|April 30, 2025
Clinical Relevance of Starting Alectinib at a Reduced Dose in Patients with ALK-Positive Non-Small Cell Lung CancerJunkyu Kim, Min-Ji Kim, Jinyong Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2013
Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinomaJong-Mu Sun, Maruja Lira, Kinnari Pandya, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 13, 2020
Utility of positron emission-computed tomography for predicting pathological response in resectable oesophageal squamous cell carcinoma after neoadjuvant chemoradiationJiyun Lee, Joon Young Choi, Sung Won Lim, et al.
Cancer|January 2, 2024
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis BJoohyun Hong, Jiyun Lee, Sehhoon Park, et al.
Clinical Genitourinary Cancer|October 12, 2015
A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial CarcinomaYoung Saing Kim, Soon Il Lee, Se Hoon Park, et al.
Lung Cancer (Amsterdam, Netherlands)|June 7, 2020
Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancerHyun Ae Jung, Jae Myoung Noh, Jong-Mu Sun, et al.
Pageof 35